Residual adverse changes in arterial endothelial function and LDL oxidation after a mild systemic inflammation induced by influenza vaccination

Annals of Medicine

Volumn 39, Issue 5, 2007, Pages 392-399

  Liuba, Petru ^a   Aburawi, Elhadi H ^a   Pesonen, Erkki ^a   Andersson, Sture ^b   Truedsson, Lennart ^a   Ylä Herttuala, Seppo ^c   Holmberg, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Artery; Endothelium; Oxidation; Postinflammatory

Indexed keywords

C REACTIVE PROTEIN; CYCLIC GMP; FIBRINOGEN; GLYCERYL TRINITRATE; INFLUENZA VACCINE; LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; ARTERY ENDOTHELIUM; ARTERY INTIMA PROLIFERATION; ARTHRALGIA; ARTICLE; CONTROLLED STUDY; FATIGUE; HEADACHE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; INFLUENZA VACCINATION; LIPID OXIDATION; MALE; MYALGIA; PRIORITY JOURNAL; SIDE EFFECT; VASCULAR DISEASE;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CAROTID ARTERY, COMMON; CHOLESTEROL, HDL; CYCLIC GMP; ENDOTHELIUM, VASCULAR; FIBRINOGEN; FOLLOW-UP STUDIES; HUMANS; HYPEREMIA; INFLAMMATION; INFLUENZA VACCINES; LIPOPROTEINS, LDL; MALE; NITROGLYCERIN; RESEARCH DESIGN; VASODILATION; VASODILATOR AGENTS;

EID: 34547912893     PISSN: 07853890     EISSN: 16512219     Source Type: Journal    
DOI: 10.1080/07853890701390111     Document Type: Article

References (37)

1. Pai J, Pischon T, Ma J, Manson J, Hankinson S, Joshipura K, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004;351:2599-610.
2. Ridker P, Hennekens C, Buring J, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-43.
3. Anderson J, Allen Maycock C, Lappe D, Crandall B, Horne B, Bair T, et al., Intermountain Heart Collaborative Study Group. Frequency of elevation of C-reactive protein in atrial fibrillation. Am J Cardiol. 2004;94:1255-9.
4. Meier C, Jick S, Derby L, Vasilakis C, Jick H. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet. 1998;351:1467-71.
5. Mamode N, Cobbe S, Pollock J. Infarcts after surgery. BMJ. 1995;310:1215-16.
6. Valtonen V, Kuikka A, Syrjänen J. Thrombo-embolic complications in bacteraemic infections. Eur Heart J. 1993;14 Suppl K:20-3.
7. Vallance P, Collier J, Bhagat K. Infection, inflammation, and infarction: dose acute endothelial dysfunction provide a link? Lancet. 1997;349:1391-2.
8. Hingorani A, Cross J, Kharbanda R, Mullen M, Bhagat K, Taylor M, et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation. 2000;102:994-9.
9. Vita J, Keaney J Jr, Larson M, Keyes M, Massaro J, Lipinska I, et al. Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation. 2004;110:3604-9.
10. Bhagat K, Collier J, Vallance P. Endothelial stunning following a brief exposure to endotoxin: a mechanism to link infection to infarction? Cardiovasc Res. 1996;32:822-9.
11. Walzog B, Gaehtgens P. Adhesion molecules: the path to a new understanding of acute inflammation. News Physiol Sci. 2000;15:107-13.
12. Mueller C, Laude K, McNally J, Harrison D. Redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol. 2005;25:274-8.
13. Varani J, Ward P. Mechanisms of endothelial cell injury in acute inflammation. Shock. 1994;2:311-9.
14. Albertini R, Moratti R, De Luca G. Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies. Curr Mol Med. 2002;2:579-92.
15. Corretti M, Anderson T, Benjamin E, Celermajer D, Charbonneau F, Creager M, et al., International Brachial Artery Reactivity Task Force, Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257-65.
16. Persson J, Stavenow L, Wikstrand J, Israelsson B, Formgren J, Berglund G. Noninvasive quantification of atherosclerosis. Reproducibility of ultrasonographic measurement of arterial wall thickness and plaque size. Arterioscler Thromb Vasc Biol. 1992;12:261-6.
17. Faxon D, Fuster V, Libby P, Beckman J, Hiatt W, Thompson R, et al., American Heart Association, Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. Circulation. 2004;109:2617-25.
18. Savage C. The interaction of endothelial cells with inflammatory cells in vasculitis. Sarcoidosis Vasc Diffuse Lung Dis. 1996;13:214-6.
19. Grahame-Clarke C, Chan N, Andrew D, Ridgway G, Betteridge D, Emery V, et al. Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation. 2003;108:678-83.
20. Booth A, Wallace S, McEniery C, Yasmin. , Brown J, Jayne D, et al. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum. 2004;50:581-8.
21. Booth A, Jayne D, Kharbanda R, McEniery C, Mackenzie I, Brown J, et al. Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation. Circulation. 2004;109:1718-23.
22. Sola S, Mir M, Cheema F, Khan-Merchant N, Menon R, Parthasarathy S, et al. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study. Circulation. 2005;111:343-8.
23. Clapp BR, Hirschfield GM, Storry C, Gallimore JR, Stidwill RP, Singer M, et al. Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation. 2005;111:1530-6.
24. Jarvisalo MJ, Harmoinen A, Hakanen M, Paakkunainen U, Viikari J, Hartiala J, et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol. 2002;22:1323-8.
25. Mamode N, Cobbe S, Pollock J. Infarcts after surgery. BMJ. 1995;310:1215-16.
26. Elahi M, Hadjinikolaou L, Galinanes M. Incidence and clinical consequences of atrial fibrillation within 1 year of first-time isolated coronary bypass surgery. Circulation. 2003;108 Suppl 1:207-12.
27. Liuba P, Persson J, Luoma J, Yla-Herttuala S, Pesonen E. Acute infections in children are accompanied by oxidative modification of LDL and decrease of HDL cholesterol, and are followed by thickening of carotid intima-media. Eur Heart J. 2003;6:515-21.
28. Liuba P, Karnani P, Pesonen E, Paakkari I, Forslid A, Johansson L, et al. Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knock-out mice. Circulation. 2000;102:1039-44.
29. Posthouwer D, Voorbij H, Grobbee D, Numans M, van der Bom J. Influenza and pneumococcal vaccination as a model to assess C-reactive protein response to mild inflammation. Vaccine. 2004;23:362-5.
30. Venugopal S, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation. 2002;106:1439-41.
31. Madjid M, Awan I, Ali M, Frazier L, Casscells W. Influenza and atherosclerosis: vaccination for cardiovascular disease. Expert Opin Biol Ther. 2005;5:91-6.
32. Hak E, Buskens E, van Essen GA, de Bakker DH, Grobbee DE, Tacken MA, et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med. 2005;65:274-80.
33. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003;348:1322-32.
34. Ahmed AE, Nicholson KG, Nguyen-Van-Tam JS. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet. 1995;346:591-5.
35. Shoenfeld Y, Wu R, Dearing LD, Matsuura E. Are antioxidized low-density lipoprotein antibodies pathogenic or protective? Circulation. 2004;110:2552-8.
36. Ritter O, Bonz A, Strotmann J, Langenfeld H. Myocardial infarction after influenza vaccination. Z Kardiol. 2003;92:962-5.
37. Smeeth L, Thomas S, Hall A, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351:2611-8.